![Francesco Galimi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francesco Galimi
Director/Board Member at
GENENTA SCIENCE S.P.A.
Net worth: - $ as of 2026-05-30
Profile
Francesco Galimi currently works at Genenta Science SpA, as Director from 2025 and Adicet Therapeutics, Inc., as Chief Medical Officer & Senior Vice President from 2019.
Dr. Galimi also formerly worked at Amgen, Inc., as General Manager-Global Program from 2015 to 2019, Onyx Pharmaceuticals, Inc., as Head-Clinical Development from 2014 to 2015, resTORbio, Inc., as Chief Medical Officer & Senior Vice President, and Adicet Bio, Inc., as Chief Medical Officer & Senior Vice President from 2019 to 2025.
Dr. Galimi received his doctorate degree from the University of Torino School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENENTA SCIENCE SPA -.--% | 2026-03-29 | 0 ( -.--% ) | - $ | 2026-05-30 |
Francesco Galimi active positions
| Companies | Position | Start |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Director/Board Member | 2024-12-31 |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Chief Tech/Sci/R&D Officer | 2019-08-31 |
Former positions of Francesco Galimi
| Companies | Position | End |
|---|---|---|
| ADICET BIO, INC. | Chief Tech/Sci/R&D Officer | 2025-01-12 |
| AMGEN INC. | Corporate Officer/Principal | 2018-12-31 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 2014-12-31 |
| ADICET BIO, INC. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Genenta Science SpA
 Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Adicet Bio, Inc.
 Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
- Stock Market
- Insiders
- Francesco Galimi
